• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

间充质干细胞归巢至血脑屏障的方法

Methods of Mesenchymal Stem Cell Homing to the Blood-Brain Barrier.

作者信息

Conaty Peter, Sherman Lauren S, Naaldijk Yahaira, Ulrich Henning, Stolzing Alexandra, Rameshwar Pranela

机构信息

Division of Hematology/Oncology, Department of Medicine, New Jersey Medical School, Rutgers School of Biomedical Health Science, Newark, NJ, USA.

Institute of Chemistry, University of Sao Paulo, Sao Paulo, Brazil.

出版信息

Methods Mol Biol. 2018;1842:81-91. doi: 10.1007/978-1-4939-8697-2_6.

DOI:10.1007/978-1-4939-8697-2_6
PMID:30196403
Abstract

Mesenchymal stem/stromal cells (MSC) are multipotent cells that can be isolated from adult and fetal tissues. In vitro, MSCs show functional plasticity by differentiating into specialized cells of all germ layers. MSCs are of relevant to medicine and have been proposed for several disorders. MSCs can be transplanted across allogeneic barriers as "off the shelf" cells. This chapter focuses on methods to deliver MSCs to the brain because neurological pathology such as damage due to stroke can lead to debilitating mental and physical problems. In general, neurological diseases are difficult to treat, partly due to the challenge in getting drugs across the blood-brain barrier (BBB). MSCs as well as other stem cells can cross the BBB. The described method begins to develop procedures, leading to efficient delivery of drugs to the brain. Here describe how MSCs can be propagated from bone marrow aspirates and their utility in delivering small RNA to the brain. The chapter discusses the issue to enhance efficient delivery of MSCs to the brain.

摘要

间充质干/基质细胞(MSC)是一类多能细胞,可从成人和胎儿组织中分离得到。在体外,MSC通过分化为所有胚层的特化细胞表现出功能可塑性。MSC与医学相关,已被应用于多种疾病的治疗。MSC可作为“现成可用”的细胞跨越同种异体屏障进行移植。本章重点介绍将MSC递送至大脑的方法,因为诸如中风导致的损伤等神经病理学情况可引发使人衰弱的精神和身体问题。一般来说,神经疾病难以治疗,部分原因在于药物穿越血脑屏障(BBB)存在挑战。MSC以及其他干细胞能够穿越BBB。所描述的方法开始开发相关程序,以实现向大脑高效递送药物。在此描述如何从骨髓抽吸物中扩增MSC及其在向大脑递送小RNA方面的效用。本章讨论了提高MSC向大脑高效递送的相关问题。

相似文献

1
Methods of Mesenchymal Stem Cell Homing to the Blood-Brain Barrier.间充质干细胞归巢至血脑屏障的方法
Methods Mol Biol. 2018;1842:81-91. doi: 10.1007/978-1-4939-8697-2_6.
2
Effects of over-expression of SOD2 in bone marrow-derived mesenchymal stem cells on traumatic brain injury.过表达 SOD2 对骨髓间充质干细胞外伤性脑损伤的影响。
Cell Tissue Res. 2018 Apr;372(1):67-75. doi: 10.1007/s00441-017-2716-7. Epub 2017 Oct 30.
3
In utero transplantation of human bone marrow-derived multipotent mesenchymal stem cells in mice.人骨髓来源的多能间充质干细胞在小鼠子宫内的移植
J Orthop Res. 2006 Mar;24(3):301-12. doi: 10.1002/jor.20047.
4
Targeted homing of CCR2-overexpressing mesenchymal stromal cells to ischemic brain enhances post-stroke recovery partially through PRDX4-mediated blood-brain barrier preservation.靶向过表达 CCR2 的间充质基质细胞归巢至缺血性脑,部分通过 PRDX4 介导的血脑屏障保护促进卒中后恢复。
Theranostics. 2018 Nov 12;8(21):5929-5944. doi: 10.7150/thno.28029. eCollection 2018.
5
Cell Therapy of Stroke: Do the Intra-Arterially Transplanted Mesenchymal Stem Cells Cross the Blood-Brain Barrier?脑卒中的细胞治疗:经动脉移植的间充质干细胞是否能穿越血脑屏障?
Cells. 2021 Nov 3;10(11):2997. doi: 10.3390/cells10112997.
6
[Study on mesenchymal stem cells entering the brain through the blood-brain barrier].间充质干细胞通过血脑屏障进入脑内的研究
Zhonghua Er Ke Za Zhi. 2004 Dec;42(12):920-3.
7
Mesenchymal stem cells.间充质干细胞。
Cell Transplant. 2011;20(1):5-14. doi: 10.3727/096368910X.
8
Mesenchymal stem cells regulate blood-brain barrier integrity through TIMP3 release after traumatic brain injury.间质干细胞通过创伤性脑损伤后 TIMP3 的释放来调节血脑屏障的完整性。
Sci Transl Med. 2012 Nov 21;4(161):161ra150. doi: 10.1126/scitranslmed.3004660.
9
The inhibitory effect of mesenchymal stem cell on blood-brain barrier disruption following intracerebral hemorrhage in rats: contribution of TSG-6.间充质干细胞对大鼠脑出血后血脑屏障破坏的抑制作用:TSG-6的作用
J Neuroinflammation. 2015 Apr 1;12:61. doi: 10.1186/s12974-015-0284-x.
10
5-Azacytidine-treated human mesenchymal stem/progenitor cells derived from umbilical cord, cord blood and bone marrow do not generate cardiomyocytes in vitro at high frequencies.经5-氮杂胞苷处理的源自脐带、脐血和骨髓的人间充质干/祖细胞在体外并不能高频产生心肌细胞。
Vox Sang. 2008 Aug;95(2):137-48. doi: 10.1111/j.1423-0410.2008.01076.x. Epub 2008 Jun 28.

引用本文的文献

1
Mesenchymal Stem Cell-Derived Extracellular Vesicles: Emerging Therapies for Neurodegenerative Diseases.间充质干细胞衍生的细胞外囊泡:神经退行性疾病的新兴疗法
Int J Nanomedicine. 2025 Jul 2;20:8547-8565. doi: 10.2147/IJN.S526945. eCollection 2025.
2
Engineering Exosomes for CNS Disorders: Advances, Challenges, and Therapeutic Potential.用于中枢神经系统疾病的工程化外泌体:进展、挑战与治疗潜力
Int J Mol Sci. 2025 Mar 28;26(7):3137. doi: 10.3390/ijms26073137.
3
Prospects of induced pluripotent stem cells in treating advancing Alzheimer's disease: A review.
诱导多能干细胞治疗晚期阿尔茨海默病的前景:综述
Histol Histopathol. 2025 Feb;40(2):157-170. doi: 10.14670/HH-18-766. Epub 2024 May 21.
4
MSC-Based Cell Therapy in Neurological Diseases: A Concise Review of the Literature in Pre-Clinical and Clinical Research.基于间充质干细胞的神经疾病细胞治疗:临床前和临床研究文献的简明综述。
Biomolecules. 2024 Apr 30;14(5):538. doi: 10.3390/biom14050538.
5
Mesenchymal-Stem-Cell-Based Therapy against Gliomas.基于间充质干细胞的脑胶质瘤治疗。
Cells. 2024 Apr 2;13(7):617. doi: 10.3390/cells13070617.
6
Impaired receptivity of thin endometrium: therapeutic potential of mesenchymal stem cells.薄型子宫内膜容受性不良:间充质干细胞的治疗潜力。
Front Endocrinol (Lausanne). 2024 Jan 25;14:1268990. doi: 10.3389/fendo.2023.1268990. eCollection 2023.
7
The Therapeutic Mechanisms of Mesenchymal Stem Cells in MS-A Review Focusing on Neuroprotective Properties.间充质干细胞治疗多发性硬化症的机制:综述神经保护特性。
Int J Mol Sci. 2024 Jan 23;25(3):1365. doi: 10.3390/ijms25031365.
8
Recent advances of engineered oncolytic viruses-based combination therapy for liver cancer.工程化溶瘤病毒联合治疗肝癌的最新进展。
J Transl Med. 2024 Jan 2;22(1):3. doi: 10.1186/s12967-023-04817-w.
9
Noninvasive Delivery of Biologicals to the Brain.生物制剂向大脑的无创递送。
Focus (Am Psychiatr Publ). 2022 Jan;20(1):64-70. doi: 10.1176/appi.focus.20210028. Epub 2022 Jan 25.
10
Rationale for the Use of Cord Blood in Hypoxic-Ischaemic Encephalopathy.在缺氧缺血性脑病中使用脐带血的理论依据。
Stem Cells Int. 2022 May 11;2022:9125460. doi: 10.1155/2022/9125460. eCollection 2022.